1. Home
  2. WAT vs BAP Comparison

WAT vs BAP Comparison

Compare WAT & BAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WAT
  • BAP
  • Stock Information
  • Founded
  • WAT 1958
  • BAP 1889
  • Country
  • WAT United States
  • BAP Peru
  • Employees
  • WAT N/A
  • BAP N/A
  • Industry
  • WAT Biotechnology: Laboratory Analytical Instruments
  • BAP Major Banks
  • Sector
  • WAT Industrials
  • BAP Finance
  • Exchange
  • WAT Nasdaq
  • BAP Nasdaq
  • Market Cap
  • WAT 17.8B
  • BAP 21.1B
  • IPO Year
  • WAT 1995
  • BAP 1995
  • Fundamental
  • Price
  • WAT $295.50
  • BAP $266.18
  • Analyst Decision
  • WAT Hold
  • BAP Buy
  • Analyst Count
  • WAT 14
  • BAP 6
  • Target Price
  • WAT $374.07
  • BAP $234.83
  • AVG Volume (30 Days)
  • WAT 586.5K
  • BAP 392.9K
  • Earning Date
  • WAT 10-31-2025
  • BAP 11-06-2025
  • Dividend Yield
  • WAT N/A
  • BAP 4.14%
  • EPS Growth
  • WAT 10.77
  • BAP 26.90
  • EPS
  • WAT 11.09
  • BAP 22.19
  • Revenue
  • WAT $3,046,056,000.00
  • BAP $5,576,317,301.00
  • Revenue This Year
  • WAT $7.19
  • BAP $25.32
  • Revenue Next Year
  • WAT $6.40
  • BAP $6.46
  • P/E Ratio
  • WAT $26.65
  • BAP $11.99
  • Revenue Growth
  • WAT 5.89
  • BAP 20.05
  • 52 Week Low
  • WAT $275.05
  • BAP $165.51
  • 52 Week High
  • WAT $423.56
  • BAP $268.49
  • Technical
  • Relative Strength Index (RSI)
  • WAT 47.98
  • BAP 75.33
  • Support Level
  • WAT $288.90
  • BAP $262.31
  • Resistance Level
  • WAT $303.24
  • BAP $268.49
  • Average True Range (ATR)
  • WAT 8.76
  • BAP 4.77
  • MACD
  • WAT 0.63
  • BAP 0.14
  • Stochastic Oscillator
  • WAT 37.96
  • BAP 87.78

About WAT Waters Corporation

Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.

About BAP Credicorp Ltd.

Credicorp Ltd is a Peruvian financial services company. It operates in four business lines, including Universal Banking, Insurance and Pensions, Microfinance, and Investment Management & Advisory. Its subsidiaries include Banco de Credito del Peru, Prima AFP, and Credicorp Capital. Geographically, the company operates in Peru, Colombia, Bolivia, Chile, Panama, the USA, and Mexico; the majority of its revenue is generated from Peru.

Share on Social Networks: